ESG Report

Overview

The report presents ADVANZ PHARMA's reshaped ESG strategy around patients, responsible operations and people, underpinned by a double materiality assessment and seven identified SDG alignments. For 2022, Scope 1 emissions were 451 tCO2e and market-based Scope 2 emissions were 179 tCO2e; the company set a 50% reduction target for both by 2030 against a 2022 baseline. The report also highlights 640+ employees, 49% women in the workforce, and 87% pulse-survey satisfaction. It describes supplier engagement, patient-access initiatives, and maintained ISO 37001 and ISO 27001 certifications.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022-2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services